Elecsys CK-MB 07027087190Recalls & reported problems
Roche Diagnostics GmbH · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04015630939978), received between Mar 23, 2023 and Sep 17, 2026 — classified as 3 malfunctions.
The most frequently reported specific device problem is “High Test Results” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results3
- Non Reproducible Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 17, 2026High Test Results
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50805776 ↗MalfunctionJun 6, 2023High Test Results; High Test Results
THERE WAS AN ALLEGATION OF A QUESTIONABLE CK-MB ELECSYS E2G RESULT FROM AN UNKNOWN ROCHE ANALYZER. THERE WAS AN ALLEGATION THAT MACRO-CK WAS INTERMITTENTLY DETECTED. REFER TO THE ATTACHMENT TO THE MEDWATCH FOR ALL PATIENT DATA. THE QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17073474 ↗MalfunctionMar 23, 2023High Test Results; Non Reproducible Results; High Test Results; Non Reproducible Results
THE INITIAL REPORTER COMPLAINED OF A DISCREPANT HIGH RESULT FOR 1 PATIENT SAMPLE TESTED FOR ELECSYS CK-MB (CK-MB) ON A COBAS E 801 ANALYTICAL UNIT. THE INITIAL RESULT WAS 83.8 NG/ML. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. ON (B)(6) 2023 A NEW SAMPLE WAS OBTAINED AND THE CK-MB RESULT WAS 1.65 NG/ML. THE CUSTOMER NOTED THAT THE INITIAL CK-MB RESULT WAS GREATER THAN THE PATIENT'S INITIAL CK RESULT AND PULLED THE ORIGINAL SAMPLE FOR RE-TESTING. ON (B)(6) 2023 THE ORIGINAL SAMPLE WAS REPEATED WITH A CK-MB RESULT OF 2.52 NG/ML. THE E801 MODULE SERIAL NUMBER WAS (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16600627 ↗
Other COLORIMETRIC METHOD, CPK OR ISOENZYMES devices
- Dimension Mass Creatine Kinase MB Isoenzyme Flex reagent cartridge 10444904Siemens Healthcare Diagnostics Inc. · COLORIMETRIC METHOD, CPK OR ISOENZYMES5 reports
- Dimension Mass Creatine Kinase MB Isoenzyme Flex reagent cartridge 10444895Siemens Healthcare Diagnostics Inc. · COLORIMETRIC METHOD, CPK OR ISOENZYMES2 reports
- Dimension Vista® Flex® reagent cartridge MMB 10445097Siemens Healthcare Diagnostics Inc. · COLORIMETRIC METHOD, CPK OR ISOENZYMES1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page